InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Hunt Hazel, Directeur Scientifique. Director active across 2 companies, notably Corcept Therapeutics INC. Cumulatively, 9 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €579k. History available since 14 July 2021. The latest transaction was filed on 9 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hunt Hazel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
150,000 股@ US$3.8821.1% 占其流量Common StockSEC:0001193125-26-046881:0
150,000 股@ US$3.2926.1% 占其流量Common StockSEC:0000950170-25-020219:0
60,000 股@ US$2.818.5% 占其流量Common StockSEC:0000950170-24-091049:0
50,000 股@ US$3.027.5% 占其流量Common StockSEC:0000950170-24-004343:0
20,455 股@ US$30.88531.5% 占其流量Common StockSEC:0000950170-23-042785:0
50,000 股@ US$3.027.5% 占其流量Common StockSEC:0000950170-23-040803:0
50,000 股@ US$2.085.8% 占其流量Common StockSEC:0000899243-22-032305:0
40,000 股@ US$3.325.0% 占其流量Common StockSEC:0000899243-22-003573:0
50,000 股@ US$2.895.2% 占其流量Common StockSEC:0000899243-21-028678:0
9 条申报中的 9 条
About Hunt Hazel
Hunt Hazel is Directeur Scientifique and Chief Scientific Officer at CORCEPT THERAPEUTICS INC, listed on XNAS. She has filed 9 forms in total, and across the recent filings observed from 2021-07-16 to 2026-02-11, the amounts show EUR 0 of buys and EUR 579065 of sells, with Levée d'options as the most frequent transaction type.
